Back to Journals » OncoTargets and Therapy » Volume 10
Review
The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,034 | Dovepress* | 12,984+ | 2,116 | 15,100 | |
PubMed Central* | 5,050 | 1,293 | 6,343 | ||
Totals | 18,034 | 3,409 | 21,443 | ||
*Since 6 April 2017 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar